PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Magnetite nanoparticles are proposed for use in magnetic hyperthermia, targeted drug delivery, genotherapy, and protein therapy to improve selectivity for neoplastic cells [PMID:35683663].
PCL/magnetite scaffolds were found to be cytocompatible and improved the adhesion and proliferation of MC3T3-E1 pre-osteoblast cells in vitro [PMID:31766520].
External magnets alone did not significantly extract or lighten magnetite ink tattoos in rats; however, a magnetic field applied immediately after Q-switched ruby laser treatment extracted some ink when epidermal injury was present [PMID:12210596].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 12210596 (2002) — Magnetite tattoos. · Lasers in surgery and medicine
- 2.PMID: 27385627 (2016) — Bioinspired synthesis of magnetite nanoparticles. · Chemical Society reviews
- 3.PMID: 26382301 (2015) — Magnetic microbes: Bacterial magnetite biomineralization. · Seminars in cell & developmental biology
- 4.PMID: 33915292 (2022) — Magnetite nanoparticles: Synthesis methods - A comparative review. · Methods (San Diego, Calif.)
- 5.PMID: 31766520 (2019) — 3D Cytocompatible Composites of PCL/magnetite. · Materials (Basel, Switzerland)